Ken Shiraiwa

5PUBLICATIONS
8CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyPredictive and prognostic markersToxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 17, 2026
Risk factors associated with febrile neutropenia in patients with esophageal cancer receiving 5-fluorouracil plus cisplatin combination chemoradiotherapy.

|Jul 31, 2026
High-throughput UHPLC-MS/MS Assay for the Quantification of Venetoclax in Patients with Acute Myeloid Leukemia and Assessment of Clinical Application: A Short Communication.

|Mar 17, 2025
Impact of Cancer Cachexia Progression on OATP1B1 Transport Activity: Quantitative Analysis Using Coproporphyrin-I as an Endogenous Biomarker.

Takahiro Sumimoto, Ryota Tanaka, Yosuke Suzuki

|Oct 20, 2021
Exacerbation of cancer pain after administering immune checkpoint inhibitor in a patient taking opioids: A case report.

Takahiro Sumimoto, Ryota Tanaka, Ken Shiraiwa

|Mar 26, 2021
Effect of S-1 on blood levels of phenobarbital and phenytoin: A case report.

Ken Shiraiwa, Hiroyuki Ono, Ryota Tanaka

Pageof 1

Frequent Collaborators

3 joint publications

Ryota Tanaka

2 joint publications

Takahiro Sumimoto

2 joint publications

Ryosuke Tatsuta

1 joint publications

Masafumi Inomata